LadaTech Serves Illumina with IP Infringement Suit | GenomeWeb

NEW YORK (GenomeWeb News) – LadaTech said after the close of the market yesterday that it has served Illumina with its previously filed patent infringement suit.

The Larchmont, NY-based firm, which is jointly owned by GlaxoSmithKline and IP Finance Holdings, initially filed the suit in August.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.